Literature DB >> 2989602

Establishment and characterization of the human cholangiocarcinoma cell line HChol-Y1 in a serum-free, chemically defined medium.

N Yamaguchi, H Morioka, H Ohkura, S Hirohashi, K Kawai.   

Abstract

A human cholangiocarcinoma cell line, designated as HChol-Y1, was established in a protein-free, chemically defined medium after a very short period of primary culture in 0.1% fetal bovine serum (FBS)-containing medium. The cell line has been propagated in this medium for 2 years. The cells grew as a monolayer and the doubling time was about 52 hours. Addition of FBS did not stimulate cell growth (population-doubling time = 50 hr) or increase saturation density. The cells grown in a protein-free medium secreted small amounts of carcinoembryonic antigen (CEA) and large amounts of carbohydrate antigen (CA) 19/9 (CEA: 12.5 +/- 2.1 ng/10(6) cells/48 hr; CA 19/9: 760 +/- 52 IU/10(6) cells/48 hr); these tumor markers were immunohistochemically demonstrated in HChol-Y1 cells. Addition of FBS slightly stimulated the production of CEA and CA 19/9. The HChol-Y1 cell line was xenotransplantable in athymic nude mice and increased the serum CEA and CA 19/9 levels in the tumor-bearing nude mice. For determination as to whether a human carcinoma cell line can proliferate and secrete CEA and CA 19/9 in synthetic medium without any protein supplements, the cells were cultivated long term (2 yr) in a protein-free, chemically defined medium. When this method of cultivation is used, it is easy to purify these substances from spent medium, because contaminating antigens such as FBS or other substances usually added to cultures are absent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989602

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  11 in total

1.  Characterization of a novel rat cholangiocarcinoma cell culture model-CGCCA.

Authors:  Chun-Nan Yeh; Kun-Ju Lin; Tsung-Wen Chen; Ren-Ching Wu; Lee-Cheng Tsao; Ying-Tzu Chen; Wen-Hui Weng; Miin-Fu Chen
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

2.  Kinetics of carcinoembryonic antigen and carbohydrate antigen 19-9 production in a human pancreatic cancer cell line (SUIT-2).

Authors:  T Iwamura; T Katsuki
Journal:  Gastroenterol Jpn       Date:  1987-10

3.  Establishment of a novel orthotopic xenograft model of human gallbladder carcinoma.

Authors:  Jan-Hendrik Egberts; Bodo Schniewind; Clemens Schafmayer; Marie-Luise Kruse; Bence Sipos; Fred Fändrich; Holger Kalthoff; Jürgen Tepel
Journal:  Clin Exp Metastasis       Date:  2007-04-04       Impact factor: 5.150

4.  High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo.

Authors:  M Watanabe; M Chigusa; H Takahashi; J Nakamura; H Tanaka; T Ohno
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

5.  Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100).

Authors:  Banchob Sripa; Saman Leungwattanawanit; Takayuki Nitta; Chaisiri Wongkham; Vajarabhongsa Bhudhisawasdi; Anucha Puapairoj; Chongrak Sripa; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

6.  A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium.

Authors:  M Miyagiwa; T Ichida; T Tokiwa; J Sato; H Sasaki
Journal:  In Vitro Cell Dev Biol       Date:  1989-06

Review 7.  Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines.

Authors:  Abdulkadir Isidan; Ali Yenigun; Daiki Soma; Eric Aksu; Kevin Lopez; Yujin Park; Arthur Cross-Najafi; Ping Li; Debjyoti Kundu; Michael G House; Sanjukta Chakraborty; Shannon Glaser; Lindsey Kennedy; Heather Francis; Wenjun Zhang; Gianfranco Alpini; Burcin Ekser
Journal:  Am J Pathol       Date:  2022-05-28       Impact factor: 5.770

8.  Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.

Authors:  Giuliana Cavalloni; Caterina Peraldo-Neia; Chiara Varamo; Laura Casorzo; Carmine Dell'Aglio; Paola Bernabei; Giovanna Chiorino; Massimo Aglietta; Francesco Leone
Journal:  Tumour Biol       Date:  2015-10-20

Review 9.  Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type.

Authors:  Meng-Shin Shiao; Khajeelak Chiablaem; Varodom Charoensawan; Nuttapong Ngamphaiboon; Natini Jinawath
Journal:  Front Genet       Date:  2018-08-15       Impact factor: 4.599

Review 10.  The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.

Authors:  Abigail Zabron; Robert J Edwards; Shahid A Khan
Journal:  Dis Model Mech       Date:  2013-03       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.